Skip to content
10-Q

Quarterly Report

Applied Therapeutics, Inc.

0000950170-25-108172

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 144.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 145.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 144.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 152.39M sh
Shares Diluted Q2 2025 · Jun 30, 2024 134.63M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$48.98M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$41.51M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $30.42M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $79.4M
Stockholders Equity Q2 2025 · Jun 30, 2025 $17.44M
Stockholders Equity Q2 2025 · Mar 31, 2025 $36.67M
Stockholders Equity Q2 2025 · Dec 31, 2024 $57.01M
Stockholders Equity Q2 2025 · Jun 30, 2024 $72.39M
Stockholders Equity Q2 2025 · Mar 31, 2024 $67.29M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$17.15M
Current Liabilities Q2 2025 · Jun 30, 2025 $17.75M
Current Liabilities Q2 2025 · Dec 31, 2024 $27.3M
Total Liabilities Q2 2025 · Jun 30, 2025 $19.9M
Total Liabilities Q2 2025 · Dec 31, 2024 $29.69M
Current Assets Q2 2025 · Jun 30, 2025 $34.51M
Current Assets Q2 2025 · Dec 31, 2024 $83.65M
Total Assets Q2 2025 · Jun 30, 2025 $37.34M
Total Assets Q2 2025 · Dec 31, 2024 $86.69M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.60
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.30
Eps Basic Q2 2025 · Jun 30, 2024 $0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.60
Sga Expense Q2 2025 · Jun 30, 2025 $13.18M
Sga Expense Q2 2025 · Jun 30, 2025 $30.86M
Sga Expense Q2 2025 · Jun 30, 2024 $10.58M
Sga Expense Q2 2025 · Jun 30, 2024 $19.65M
Rd Expense Q2 2025 · Jun 30, 2025 $9.92M
Rd Expense Q2 2025 · Jun 30, 2025 $17.76M
Rd Expense Q2 2025 · Jun 30, 2024 $10M
Rd Expense Q2 2025 · Jun 30, 2024 $22.22M
Net Income Q2 2025 · Jun 30, 2025 −$21.33M
Net Income Q2 2025 · Jun 30, 2025 −$43.16M
Net Income Q2 2025 · Mar 31, 2025 −$21.83M
Net Income Q2 2025 · Jun 30, 2024 $2.9M
Net Income Q2 2025 · Jun 30, 2024 −$81.04M
Net Income Q2 2025 · Mar 31, 2024 −$83.94M
Operating Income Q2 2025 · Jun 30, 2025 −$23.1M
Operating Income Q2 2025 · Jun 30, 2025 −$48.62M
Operating Income Q2 2025 · Jun 30, 2024 −$20.44M
Operating Income Q2 2025 · Jun 30, 2024 −$41.53M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $144K
Revenue Q2 2025 · Jun 30, 2024 $334K